eXoZymes, Inc.

Healthcare · Biotechnology · United States

Last price 4.13 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 38.33M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.